PATENT CLAIM ANALYSIS

Application Number: 15775328
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-07
Patent Classification: ["424", "133100"]

Abstract:
The composition of anti-TNFR2 antibodies are provided, as well as methods of their preparation and use. This includes methods for treating disorders associated with TNF and/or TNFR2, such as cancer.

Claim (Index 122):
The humanized anti-TNFR2 antibody of  claim 117 , wherein said anti-TNFR2 antibody comprises a set of three HCDRs and three LCDRs, wherein the set of three HCDRs and three LCDRs are selected from the group consisting of:\n a) SEQ ID NOs: 46-48 (HCDRs) and either SEQ ID NOs: 49-51 (LCDRs) or SEQ ID NOs: 52-54 (LCDRs); and b) SEQ ID NOs: 55-57 (HCDRs) and either SEQ ID NOs: 58-60 (LCDRs) or SEQ ID NOs: 61-63 (LCDRs).

Metadata:
- Claim Count in Document: 35.0
- Percentile: 93.0
- Lexical Diversity: 1.21429
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15849771', '14662349', '14031075', '15223434', '15820054']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7905671157144684
- 35 USC 102 Novelty (BERT): 0.5343386340419862
- Combined Prediction Score: 0.7649442675472202
- Mean Citation Score: 361.482638
- Max Citation Score: 378.9163
- Similarity Product: 279.85823484536405

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test